[EN] EPIDITHIODIKETOPIPERAZINE COMPOUNDS, COMPOSITIONS, AND METHODS<br/>[FR] COMPOSÉS ÉPIDITHIODICÉTOPIPÉRAZINES, COMPOSITIONS ET PROCÉDÉS
申请人:GLOBAVIR BIOSCIENCES INC
公开号:WO2015095821A1
公开(公告)日:2015-06-25
Epidithiodiketopiperazine compounds, pharmaceutical compositions based thereon and methods of their synthesis, as part of treating, inhibiting and reducing transcription and translation of hypoxia inducible genes are described. In another aspect, the present disclosure describes a method for interfering with hypoxia-induced transcriptional pathway in a cell comprising: contacting the cell with at least one compound disclosed herein. In another aspect, the present disclosure describes a method for treating breast cancer, a solid cancer, a blood cancer, a subject suffering from carcinoma in need of said treatment, and renal cell carcinoma (RCC), comprising: administering to the subject an effective amount of at least one compound disclosed herein. In some embodiments of the methods described herein, the method further comprises administering an additional anti-cancer and/or cytotoxic agent.
描述了Epidithiodiketopiperazine化合物、基于该化合物的药物组合物及其合成方法,作为治疗、抑制和减少低氧诱导基因的转录和翻译的一部分。在另一个方面,本公开说明描述了一种干扰细胞中低氧诱导转录途径的方法,包括:将细胞与至少一种本公开披露的化合物接触。在另一个方面,本公开说明描述了一种治疗乳腺癌、实体癌、血液癌、需要接受所述治疗的患有癌症的受试者以及肾细胞癌(RCC)的方法,包括:向受试者施用至少一种本公开披露的化合物的有效量。在所述方法的一些实施方式中,该方法还包括施用额外的抗癌和/或细胞毒药剂。